Bionano Genomics, Inc. NASDAQ:BNGO

Bionano Genomics stock price today

$3.258
+3.04
+1451.52%
Financial Health
0
1
2
3
4
5
6
7
8
9

Bionano Genomics stock price monthly change

-67.91%
month

Bionano Genomics stock price quarterly change

-67.91%
quarter

Bionano Genomics stock price yearly change

-90.00%
year

Bionano Genomics key metrics

Market Cap
20.37M
Enterprise value
321.81M
P/E
-2.48
EV/Sales
11.57
EV/EBITDA
-2.66
Price/Sales
11.33
Price/Book
1.26
PEG ratio
0.03
EPS
-6.02
Revenue
37.47M
EBITDA
-107.46M
Income
-226.79M
Revenue Q/Q
18.26%
Revenue Y/Y
26.92%
Profit margin
-476.93%
Oper. margin
-473.7%
Gross margin
21.38%
EBIT margin
-473.7%
EBITDA margin
-286.81%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Bionano Genomics stock price history

Bionano Genomics stock forecast

Bionano Genomics financial statements

Bionano Genomics, Inc. (NASDAQ:BNGO): Profit margin
Jun 2023 8.66M -38.91M -449.23%
Sep 2023 9.31M -112.56M -1208.05%
Dec 2023 10.72M -43.89M -409.39%
Mar 2024 8.76M -31.42M -358.33%
Bionano Genomics, Inc. (NASDAQ:BNGO): Analyst Estimates
Sep 2025 12.82M -16.50M -128.61%
Oct 2025 12.47M -14.02M -112.43%
Dec 2025 13.92M -12.00M -86.25%
Mar 2026 17.09M 0
  • Analysts Price target

  • Financials & Ratios estimates

Bionano Genomics, Inc. (NASDAQ:BNGO): Debt to assets
Jun 2023 271381000 56.62M 20.87%
Sep 2023 181904000 62.90M 34.58%
Dec 2023 214404000 118.24M 55.15%
Mar 2024 157995000 75.22M 47.61%
Bionano Genomics, Inc. (NASDAQ:BNGO): Cash Flow
Jun 2023 -36.69M 29.57M 17.88M
Sep 2023 -26.29M 33.42M 12.58M
Dec 2023 -34.3M -55.37M 73.00M
Mar 2024 -28.13M 47.58M -21.61M

Bionano Genomics alternative data

Bionano Genomics

Bionano Genomics, Inc. (NASDAQ:BNGO): Google Trends - Bionano Genomics
11 Jun 2023 8
18 Jun 2023 6
25 Jun 2023 4
2 Jul 2023 3
9 Jul 2023 4
16 Jul 2023 3
23 Jul 2023 2
30 Jul 2023 3
6 Aug 2023 3
13 Aug 2023 3
20 Aug 2023 2
27 Aug 2023 3
3 Sep 2023 2
10 Sep 2023 1
17 Sep 2023 3
24 Sep 2023 2
1 Oct 2023 1
8 Oct 2023 2
15 Oct 2023 2
22 Oct 2023 2

Genome and DNA

Bionano Genomics, Inc. (NASDAQ:BNGO): Google Trends - Genome and DNA
21 May 2023 583
28 May 2023 583
4 Jun 2023 623
11 Jun 2023 613
18 Jun 2023 714
25 Jun 2023 735
2 Jul 2023 815
9 Jul 2023 764
16 Jul 2023 754
23 Jul 2023 835
30 Jul 2023 764
6 Aug 2023 794
13 Aug 2023 794
20 Aug 2023 743
27 Aug 2023 764
3 Sep 2023 824
10 Sep 2023 743
17 Sep 2023 854
24 Sep 2023 844
1 Oct 2023 794

Numbers represent search interest relative to the highest point on the chart for the given region and time.

A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.

Bionano Genomics, Inc. (NASDAQ:BNGO): Job openings
Aug 2023 8
Sep 2023 5
Oct 2023 5
Nov 2023 2
Dec 2023 2
Jan 2024 4
Feb 2024 5
Apr 2024 1
May 2024 0
Jun 2024 1
Jul 2024 1
Dec 2024 0
Bionano Genomics, Inc. (NASDAQ:BNGO): Employee count
Aug 2023 405
Sep 2023 405
Oct 2023 405
Nov 2023 405
Dec 2023 388
Jan 2024 388
Feb 2024 388
Apr 2024 344
May 2024 344
Jun 2024 344
Jul 2024 344

Bionano Genomics other data

25.73% -1.51%
of BNGO is owned by hedge funds
72.09M -4.22M
shares is hold by hedge funds

Bionano Genomics, Inc. (NASDAQ:BNGO): Insider trades (number of shares)
Period Buy Sel
Aug 2022 0 20000
May 2023 65000 0
Jun 2023 65789 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
MAMUSZKA HANNAH director
Common Stock 65,789 $0.76 $50,000
Purchase
HOLMLIN R. ERIK director, officer: President an..
Common Stock 15,000 $0.64 $9,645
Purchase
STEWART CHRISTOPHER P. officer: Chief Financial Officer
Common Stock 50,000 $0.67 $33,400
Sale
LINNEY YVONNE director:
Common Stock 20,000 $3.62 $72,400
Option
LINNEY YVONNE director:
Common Stock 20,000 $0.38 $7,600
Option
BARKER DAVID L director:
Stock Option (Right to Buy) 44,470 N/A N/A
Purchase
BARKER DAVID L director:
Common Stock 10,000 $1.6 $16,000
Option
STEWART CHRISTOPHER P. officer: Chief Financial Officer
Common Stock 60,000 $0.56 $33,600
Purchase
HOLMLIN R. ERIK director, officer: President an..
Common Stock 150 $3.98 $597
Purchase
HOLMLIN R. ERIK director, officer: President an..
Common Stock 2,675 $3.99 $10,673
Patent
Application
Filling date: 22 Feb 2021 Issue date: 25 Aug 2022
Application
Filling date: 9 Mar 2022 Issue date: 21 Jul 2022
Grant
Filling date: 1 May 2020 Issue date: 5 Apr 2022
Grant
Filling date: 31 Aug 2015 Issue date: 5 Apr 2022
Application
Filling date: 23 Mar 2021 Issue date: 20 Jan 2022
Application
Filling date: 31 Dec 2018 Issue date: 25 Nov 2021
Application
Filling date: 8 Aug 2019 Issue date: 7 Oct 2021
Application
Filling date: 24 Jun 2019 Issue date: 29 Jul 2021
Application
Filling date: 25 Jan 2019 Issue date: 3 Jun 2021
Application
Filling date: 20 Nov 2020 Issue date: 20 May 2021
Monday, 23 December 2024
globenewswire.com
Wednesday, 13 November 2024
seekingalpha.com
globenewswire.com
Monday, 4 November 2024
globenewswire.com
Thursday, 31 October 2024
globenewswire.com
globenewswire.com
Thursday, 10 October 2024
globenewswire.com
Friday, 6 September 2024
zacks.com
Tuesday, 13 August 2024
seekingalpha.com
zacks.com
Wednesday, 7 August 2024
globenewswire.com
Wednesday, 31 July 2024
globenewswire.com
Monday, 8 July 2024
globenewswire.com
Friday, 5 July 2024
globenewswire.com
Tuesday, 2 July 2024
globenewswire.com
Thursday, 20 June 2024
globenewswire.com
Monday, 17 June 2024
globenewswire.com
Tuesday, 28 May 2024
investorplace.com
Thursday, 23 May 2024
seekingalpha.com
Friday, 10 May 2024
investorplace.com
Wednesday, 8 May 2024
seekingalpha.com
globenewswire.com
Thursday, 25 April 2024
InvestorPlace
Thursday, 29 February 2024
GlobeNewsWire
Wednesday, 28 February 2024
GlobeNewsWire
Wednesday, 7 February 2024
InvestorPlace
Wednesday, 17 January 2024
InvestorPlace
Friday, 17 November 2023
Zacks Investment Research
Wednesday, 15 November 2023
Seeking Alpha
Friday, 10 November 2023
InvestorPlace
  • What's the price of Bionano Genomics stock today?

    One share of Bionano Genomics stock can currently be purchased for approximately $3.26.

  • When is Bionano Genomics's next earnings date?

    Unfortunately, Bionano Genomics's (BNGO) next earnings date is currently unknown.

  • Does Bionano Genomics pay dividends?

    No, Bionano Genomics does not pay dividends.

  • How much money does Bionano Genomics make?

    Bionano Genomics has a market capitalization of 20.37M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 29.9% to 36.12M US dollars.

  • What is Bionano Genomics's stock symbol?

    Bionano Genomics, Inc. is traded on the NASDAQ under the ticker symbol "BNGO".

  • What is Bionano Genomics's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of Bionano Genomics?

    Shares of Bionano Genomics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Bionano Genomics have?

    As Jul 2024, Bionano Genomics employs 344 workers.

  • When Bionano Genomics went public?

    Bionano Genomics, Inc. is publicly traded company for more then 7 years since IPO on 21 Aug 2018.

  • What is Bionano Genomics's official website?

    The official website for Bionano Genomics is bionanogenomics.com.

  • Where are Bionano Genomics's headquarters?

    Bionano Genomics is headquartered at 9540 Towne Centre Drive, San Diego, CA.

  • How can i contact Bionano Genomics?

    Bionano Genomics's mailing address is 9540 Towne Centre Drive, San Diego, CA and company can be reached via phone at 858 888 7600.

Bionano Genomics company profile:

Bionano Genomics, Inc.

bionanogenomics.com
Exchange:

NASDAQ

Full time employees:

344

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

9540 Towne Centre Drive
San Diego, CA 92121

CIK: 0001411690
ISIN: US09075F3055
CUSIP: 09075F107